Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All favipiravir studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchFavipiravirFavipiravir (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Favipiravir-based treatment for outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials

Lan et al., Expert Review of Clinical Pharmacology, doi:10.1080/17512433.2022.2078701
May 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Systematic review and meta analysis of favipiravir RCTs, showing improved viral clearance and recovery, but no significant difference for mortality, ICU admission, or ventilation.
Currently there are 68 favipiravir studies and meta analysis shows:
OutcomeImprovement
Mortality12% lower [-4‑26%]
Ventilation10% higher [-23‑56%]
ICU admission31% higher [9‑56%]
Hospitalization4% higher [-13‑23%]
Lan et al., 17 May 2022, peer-reviewed, 6 authors.
This PaperFavipiravirAll
{ 'DOI': '10.1080/17512433.2022.2078701', 'ISSN': ['1751-2433', '1751-2441'], 'URL': 'http://dx.doi.org/10.1080/17512433.2022.2078701', 'alternative-id': ['10.1080/17512433.2022.2078701'], 'assertion': [ { 'label': 'Peer Review Statement', 'name': 'peerreview_statement', 'order': 1, 'value': 'The publishing and review policy for this title is described in its Aims & ' 'Scope.'}, { 'URL': 'http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ierj20', 'label': 'Aim & Scope', 'name': 'aims_and_scope_url', 'order': 2, 'value': 'http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ierj20'}, { 'group': {'label': 'Publication History', 'name': 'publication_history'}, 'label': 'Received', 'name': 'received', 'order': 0, 'value': '2022-01-15'}, { 'group': {'label': 'Publication History', 'name': 'publication_history'}, 'label': 'Revised', 'name': 'revised', 'order': 1, 'value': '2022-03-11'}, { 'group': {'label': 'Publication History', 'name': 'publication_history'}, 'label': 'Accepted', 'name': 'accepted', 'order': 2, 'value': '2022-05-03'}, { 'group': {'label': 'Publication History', 'name': 'publication_history'}, 'label': 'Published', 'name': 'published', 'order': 3, 'value': '2022-05-17'}], 'author': [ { 'affiliation': [ { 'name': 'School of Pharmaceutical Sciences and Medical Technology, Putian ' 'University, Putian, 351100, China'}], 'family': 'Lan', 'given': 'Shao-Huan', 'sequence': 'first'}, { 'affiliation': [ { 'name': 'Department of Internal Medicine, Kaohsiung Veterans General ' 'Hospital, Tainan Branch, Tainan, Taiwan'}], 'family': 'Lai', 'given': 'Chih-Cheng', 'sequence': 'additional'}, { 'affiliation': [{'name': 'Yijia Pharmacy, Tainan, 70846, Taiwan'}], 'family': 'Chang', 'given': 'Shen-Peng', 'sequence': 'additional'}, { 'affiliation': [{'name': 'School of Management, Putian University, Putian, 351100, China'}], 'family': 'Lu', 'given': 'Li-Chin', 'sequence': 'additional'}, { 'affiliation': [ { 'name': 'Division of Urology, Department of Surgery, Chi-Mei Hospital, ' 'Chia Li, Tainan, Taiwan'}], 'family': 'Hung', 'given': 'Shun-Hsing', 'sequence': 'additional'}, { 'affiliation': [ { 'name': 'Department of Orthopedic, Chi Mei Medical Center, Tainan, 71004, ' 'Taiwan'}], 'family': 'Lin', 'given': 'Wei-Ting', 'sequence': 'additional'}], 'container-title': 'Expert Review of Clinical Pharmacology', 'container-title-short': 'Expert Review of Clinical Pharmacology', 'content-domain': {'crossmark-restriction': True, 'domain': ['www.tandfonline.com']}, 'created': {'date-parts': [[2022, 5, 17]], 'date-time': '2022-05-17T08:53:10Z', 'timestamp': 1652777590000}, 'deposited': { 'date-parts': [[2022, 5, 17]], 'date-time': '2022-05-17T08:53:24Z', 'timestamp': 1652777604000}, 'indexed': {'date-parts': [[2022, 5, 17]], 'date-time': '2022-05-17T09:13:44Z', 'timestamp': 1652778824439}, 'is-referenced-by-count': 0, 'issued': {'date-parts': [[2022, 5, 17]]}, 'language': 'en', 'link': [ { 'URL': 'https://www.tandfonline.com/doi/pdf/10.1080/17512433.2022.2078701', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'member': '301', 'original-title': [], 'prefix': '10.1080', 'published': {'date-parts': [[2022, 5, 17]]}, 'published-online': {'date-parts': [[2022, 5, 17]]}, 'publisher': 'Informa UK Limited', 'reference': [ { 'key': 'cit0001', 'unstructured': 'World Health Organization. https://covid19.who.int/ Accessed on October ' '31, 2021.'}, {'DOI': '10.1016/j.jmii.2020.02.012', 'doi-asserted-by': 'publisher', 'key': 'cit0002'}, {'DOI': '10.1056/NEJMcp2009575', 'doi-asserted-by': 'publisher', 'key': 'cit0003'}, {'DOI': '10.1001/jama.2021.11330', 'doi-asserted-by': 'publisher', 'key': 'cit0004'}, {'DOI': '10.1001/jama.2020.17023', 'doi-asserted-by': 'publisher', 'key': 'cit0005'}, {'DOI': '10.1093/jac/dkab093', 'doi-asserted-by': 'publisher', 'key': 'cit0006'}, { 'DOI': '10.1016/j.jmii.2021.05.011', 'author': 'Lai CC', 'doi-asserted-by': 'crossref', 'first-page': '767', 'issue': '5', 'journal-title': 'J Microbiol Immunol Infect', 'key': 'cit0007', 'volume': '54', 'year': '2021'}, { 'author': 'Okoli GN', 'first-page': '1', 'journal-title': 'Expert Rev Anti Infect Ther', 'key': 'cit0008', 'year': '2021'}, {'DOI': '10.1136/bmjopen-2020-048416', 'doi-asserted-by': 'publisher', 'key': 'cit0009'}, {'DOI': '10.2183/pjab.93.027', 'doi-asserted-by': 'publisher', 'key': 'cit0010'}, {'DOI': '10.1016/j.antiviral.2013.09.015', 'doi-asserted-by': 'publisher', 'key': 'cit0011'}, {'DOI': '10.1111/bph.15072', 'doi-asserted-by': 'publisher', 'key': 'cit0012'}, { 'author': 'Özlüşen B', 'first-page': '1', 'journal-title': 'Eur J Clin Microbiol Infect Dis', 'key': 'cit0013', 'year': '2021'}, {'DOI': '10.1186/s12879-021-06164-x', 'doi-asserted-by': 'publisher', 'key': 'cit0014'}, {'DOI': '10.1038/s41598-021-90551-6', 'doi-asserted-by': 'publisher', 'key': 'cit0015'}, { 'author': 'Bosaeed M', 'first-page': '1', 'journal-title': 'Infect Dis Ther', 'key': 'cit0016', 'year': '2021'}, { 'author': 'Shinkai M', 'first-page': '1', 'journal-title': 'Infect Dis Ther', 'key': 'cit0017', 'year': '2021'}, { 'DOI': '10.1038/s41598-021-98683-5', 'author': 'Dabbous HM', 'doi-asserted-by': 'crossref', 'first-page': '18983', 'issue': '1', 'journal-title': 'Sci Rep', 'key': 'cit0018', 'volume': '11', 'year': '2021'}, {'DOI': '10.1016/j.jclinepi.2021.02.003', 'doi-asserted-by': 'publisher', 'key': 'cit0019'}, {'DOI': '10.1136/bmj.d5928', 'doi-asserted-by': 'publisher', 'key': 'cit0020'}, { 'key': 'cit0021', 'unstructured': 'https://clinicaltrials.gov/ct2/show/NCT04542694?term=04542694&draw=2&rank=1'}, {'DOI': '10.1016/j.ijid.2020.11.008', 'doi-asserted-by': 'publisher', 'key': 'cit0022'}, {'DOI': '10.3389/fphar.2021.683296', 'doi-asserted-by': 'publisher', 'key': 'cit0023'}, {'DOI': '10.1093/cid/ciaa1176', 'doi-asserted-by': 'publisher', 'key': 'cit0024'}, {'DOI': '10.1016/j.intimp.2021.107702', 'doi-asserted-by': 'publisher', 'key': 'cit0025'}, {'DOI': '10.1016/j.ejps.2020.105631', 'doi-asserted-by': 'publisher', 'key': 'cit0026'}, {'DOI': '10.1016/j.intimp.2021.107522', 'doi-asserted-by': 'publisher', 'key': 'cit0027'}, {'DOI': '10.1016/j.ijid.2020.11.142', 'doi-asserted-by': 'publisher', 'key': 'cit0028'}, { 'DOI': '10.1007/s42399-021-01014-y', 'author': 'Tao J', 'doi-asserted-by': 'crossref', 'first-page': '2443', 'journal-title': 'SN Compr Clin Med', 'key': 'cit0029', 'volume': '3', 'year': '2021'}, { 'DOI': '10.1016/j.ijantimicag.2022.106545', 'author': 'Hsu CK', 'doi-asserted-by': 'crossref', 'first-page': '106545', 'issue': '3', 'journal-title': 'Int J Antimicrob Agents', 'key': 'cit0030', 'volume': '59', 'year': '2022'}, { 'author': 'Sanders JM', 'first-page': '1824', 'issue': '18', 'journal-title': 'JAMA', 'key': 'cit0031', 'volume': '323', 'year': '2020'}], 'reference-count': 31, 'references-count': 31, 'relation': {}, 'resource': {'primary': {'URL': 'https://www.tandfonline.com/doi/full/10.1080/17512433.2022.2078701'}}, 'score': 1, 'short-title': [], 'source': 'Crossref', 'subject': [ 'Pharmacology (medical)', 'General Pharmacology, Toxicology and Pharmaceutics', 'General Medicine'], 'subtitle': [], 'title': 'Favipiravir-based treatment for outcomes of patients with COVID-19: a systematic review and ' 'meta-analysis of randomized controlled trials', 'type': 'journal-article', 'update-policy': 'http://dx.doi.org/10.1080/tandf_crossmark_01'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit